Literature DB >> 20696314

Unravelling the role of defective genes.

Mark R Cookson1.   

Abstract

Several genes that cause familial forms of Parkinson's disease (PD) or similar disorders have been found in recent years. The aim of this review is to cover two broad aspects of the logic of genetics. The first aspect is the recognition that PD can have a genetic basis, either for Mendelian families where genes can be identified because mutations segregate with disease or in populations where more common variants are associated with disease. There are several causal genes for both dominant and recessive forms of parkinsonism, some of which overlap with sporadic PD and some of which have more complex phenotypes. Several of the dominant loci have also been reliably identified as risk factors for sporadic PD. The second topic is how the study of multiple mutations in any given gene can help understand the role that the protein under investigation plays in PD. Examples will be given of both recessive and dominant genes for parkinsonism, showing how the analysis of multiple gene mutations can be a powerful approach for dissecting out which function(s) are important for the disease process. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696314      PMCID: PMC2955442          DOI: 10.1016/S0079-6123(10)83003-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  94 in total

1.  Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.

Authors:  Denise M Kay; Patricia Kramer; Don Higgins; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

2.  Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1.

Authors:  Guido Krebiehl; Sabine Ruckerbauer; Lena F Burbulla; Nicole Kieper; Brigitte Maurer; Jens Waak; Hartwig Wolburg; Zemfira Gizatullina; Frank N Gellerich; Dirk Woitalla; Olaf Riess; Philipp J Kahle; Tassula Proikas-Cezanne; Rejko Krüger
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

3.  Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation.

Authors:  L Narhi; S J Wood; S Steavenson; Y Jiang; G M Wu; D Anafi; S A Kaufman; F Martin; K Sitney; P Denis; J C Louis; J Wypych; A L Biere; M Citron
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

5.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

6.  The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

Authors:  Patrick A Lewis; Elisa Greggio; Alexandra Beilina; Shushant Jain; Acacia Baker; Mark R Cookson
Journal:  Biochem Biophys Res Commun       Date:  2007-04-10       Impact factor: 3.575

7.  The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.

Authors:  Elisa Greggio; Ibardo Zambrano; Alice Kaganovich; Alexandra Beilina; Jean-Marc Taymans; Veronique Daniëls; Patrick Lewis; Shushant Jain; Jinhui Ding; Ali Syed; Kelly J Thomas; Veerle Baekelandt; Mark R Cookson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

8.  A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Authors:  Rejko Krüger; Manu Sharma; Olaf Riess; Thomas Gasser; Christine Van Broeckhoven; Jessie Theuns; Jan Aasly; Grazia Annesi; Anna Rita Bentivoglio; Alexis Brice; Ana Djarmati; Alexis Elbaz; Matthew Farrer; Carlo Ferrarese; J Mark Gibson; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Christine Klein; Jean-Charles Lambert; Suzanne Lesage; Juei-Jueng Lin; Timothy Lynch; George D Mellick; Francesa de Nigris; Grzegorz Opala; Alessandro Prigione; Aldo Quattrone; Owen A Ross; Wataru Satake; Peter A Silburn; Eng King Tan; Tatsushi Toda; Hiroyuki Tomiyama; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Demetrius M Maraganore
Journal:  Neurobiol Aging       Date:  2009-12-24       Impact factor: 4.673

9.  Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

Authors:  Marcus Kostka; Tobias Högen; Karin M Danzer; Johannes Levin; Matthias Habeck; Andreas Wirth; Richard Wagner; Charles G Glabe; Sabine Finger; Udo Heinzelmann; Patrick Garidel; Wenzhen Duan; Christopher A Ross; Hans Kretzschmar; Armin Giese
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

Review 10.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

View more
  6 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: implications in Parkinson's disease.

Authors:  Hector Flavio Ortega-Arellano; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Neurochem Res       Date:  2011-03-26       Impact factor: 3.996

Review 3.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 4.  Genetics of Parkinson's disease - a clinical perspective.

Authors:  Sang-Myung Cheon; Lilian Chan; Daniel Kam Yin Chan; Jae Woo Kim
Journal:  J Mov Disord       Date:  2012-10-30

Review 5.  Rafts, Nanoparticles and Neural Disease.

Authors:  Vishal Gulati; Ron Wallace
Journal:  Nanomaterials (Basel)       Date:  2012-08-06       Impact factor: 5.076

Review 6.  DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives.

Authors:  Mariaelena Repici; Flaviano Giorgini
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.